5-(3-Allyloxyphenyl)-2-amino-5,8-dihydropyrido[2,3-d]pyrimidine-4,7(3H,6H)-dione

ID: ALA5183266

PubChem CID: 142550460

Max Phase: Preclinical

Molecular Formula: C16H16N4O3

Molecular Weight: 312.33

Names and Identifiers

Canonical SMILES:  C=CCOc1cccc(C2CC(=O)Nc3nc(N)[nH]c(=O)c32)c1

Standard InChI:  InChI=1S/C16H16N4O3/c1-2-6-23-10-5-3-4-9(7-10)11-8-12(21)18-14-13(11)15(22)20-16(17)19-14/h2-5,7,11H,1,6,8H2,(H4,17,18,19,20,21,22)

Standard InChI Key:  RBDDQWALLRHOQW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0000   -1.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144   -1.4419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289   -1.8544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289   -2.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144   -3.0919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -2.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144   -0.6171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0003   -0.2045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0010    0.6176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7155    1.0302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270    0.6212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4317   -0.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7144   -3.0919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4289   -2.6794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4289   -1.8543    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7144   -1.4419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7144   -0.6171    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1432   -3.0918    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1432   -3.0918    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132    1.0300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132    1.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4274    2.2672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4274    3.0919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  2  0
  6  5  1  0
  7  2  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
 11 10  1  0
  7 12  1  0
 12 11  2  0
  6 13  1  0
 14 13  2  0
 15 14  1  0
 16 15  1  0
  1 16  1  0
 16 17  2  0
  4 18  2  0
 14 19  1  0
  9 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA5183266

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 312.33

Molecular Weight (Monoisotopic): 312.1222

AlogP: 1.39

#Rotatable Bonds: 4

Polar Surface Area: 110.10

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.98

CX Basic pKa: 2.08

CX LogP: 0.71

CX LogD: 0.63

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.74

Np Likeness Score: -0.45

References

1. Takasaki I, Watanabe A, Okada T, Kanayama D, Nagashima R, Shudo M, Shimodaira A, Nunomura K, Lin B, Watanabe Y, Gouda H, Miyata A, Kurihara T, Toyooka N..  (2022)  Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist.,  231  [PMID:35124531] [10.1016/j.ejmech.2022.114160]

Source

Source(1):

• Scientific Literature